A general synthesis of novel quinoline-based isoindolin-1-one derivatives

Article abstract of DOI:10.3987/COM-15-13314

A simple and general one-pot protocol for the synthesis of a series quinoline-based isoindolin-l-ones, namely 7-chloro-2-substituted-2,3-dihydro- 1H-pyrrolo[3,4-b]quinolin-1-ones (5a-p) is described, involving a cascade Williamson-type condensation reacti

Full text of DOI:10.3987/COM-15-13314

HETEROCYCLES, Vol. 91, No. 11, 2015, pp. -. © 2015 The Japan Institute of Heterocyclic Chemistry
Received, 3rd September, 2015, Accepted, 2nd October, 2015, Published online, 9th October, 2015
DOI: 10.3987/COM-15-13314
A
GENERAL SYNTHESIS OF NOVEL QUINOLINE-BASED
ISOINDOLIN-1-ONE DERIVATIVES
Hong Zhang and Yang Li*
Institute of Superfine Chemicals, Bohai University, Jinzhou 121000, China
bhuzh@163.com
Abstract –ꢀA simple and general one-pot protocol for the synthesis of a series
quinoline-based isoindolin-l-ones, namely 7-chloro-2-substituted-2,3-dihydro-
1H-pyrrolo[3,4-b]quinolin-1-ones (5a-p) is described, involving a cascade
Williamson-type condensation reaction of ethyl 6-chloro-2-(chloromethyl)-
quinoline-3-carboxylate (3) with aromatic amines (4a-i), aliphatic amines (4j-m)
and aliphatic diamines (4n-p) and subsequent intramolecular C-N bond
cyclization of the resulting intermediates in refluxing EtOH–AcOH (v/v, 10:1)
solvent system in a single synthetic operation.
Isoindolin-1-ones constitute an exceptional class of structural motifs which have been found widely
present in natural products like cichorine1 and vitedoamine,2 and also in pharmacologically important
synthetic molecules such as indoprofen3 and lenalidomide.4 Consequently, attention has been increasingly
paid to use of the isoindolin-1-one molecular template for further modification and functionalization of
this class of compounds from both organic and medicinal chemists, aiming to find new applications from
these compounds.5-7
On the other hand, it is well established that bioactive heterocyclic compounds when linked with
quinoline moiety in fused or bonded forms usually results in new hybrids with potent pharmacological
properties.8-10 Thus, in light of the combination principles for drug design,11 it would be of synthetic
importance to the construction of quinoline-based isoindolin-l-one derivatives, wherein the phenyl ring
was replaced by quinoline moiety. Such compounds might be much more attractive and valuable for
medicinal chemistry and drug discovery.
A literature survey revealed that there are several examples reported concerning the synthesis of
quinoline-based isoindolin-l-one derivatives.12-16 However, all these reports are of individual and
scattered syntheses, and no efforts have been made to develop a general synthetic approach. Herein, we
wish to report a simple and general synthesis of a series of novel quinoline-based isoindolin-l-one,

namely N-substituted-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-ones through the one-pot reaction of ethyl
6-chloro-2-(chloromethyl)quinoline-3-carboxylate and various amines.
We recently reported on the reaction of 2-chloromethyl- or 2-bromomethylquinoline with phenols,17,18
salicylaldehydes,19 aromatic aldehydes,20 and quinolin-8-ols21 for the synthesis of novel
heterocycle-containing quinolines. Building on the evolving expertise and in our ongoing endeavor to
create novel quinoline-based hybrids, our present work focused on an extension of this work to the
reaction with various amines for the synthesis of novel quinoline-based isoindolin-l-one derivatives. Our
synthesis commenced with the preparation of required substrate ethyl 6-chloro-2-(chloromethyl)-
quinoline-3-carboxylate (3) as shown in Scheme 1.
Scheme 1ꢀꢀ Synthetic route for ethyl 2-(chloromethyl)quinoline-3-carboxylate (3)
N-(4-Chloro-2-formylphenyl)acetamide (2) obtained from the chlorination of the corresponding
N-(2-formylphenyl)acetamide (1) was subjected to the Friedländer annulation reaction with ethyl
4-chloro-3-oxobutanoate using chlorotrimethylsilane (TMSCl) as a promoter and water-acceptor agent in
accordance with the method as described in the literature.22 After the usual workup then purification of
crude product by column chromatography over silica gel, the required substrate 3 was obtained in 73%
yield. In addition, our attempt to follow the route as described by Atar et al.23 using lithium triflate as an
expeditious catalyst under solvent free conditions could also obtain substrate 3 in a comparable yield of
71%.
Subsequently, our attention was transferred to its reaction with aromatic amines for building the desired
quinoline-based isoindolin-l-one system as shown in Scheme 2. In fact, our initial investigation towards
the reaction was conducted under the reaction conditions as described in the literature.14 Unfortunately,
contrary to expectation, this purported approach was ineffective in our hands and the reaction did not
proceed satisfactorily, giving poor yields of highly impure products. When the reaction was carried out
using ethanol as solvent in accordance with the reaction conditions as described in the literature,16 the
desired products could be obtained, but this was still plagued by low yields of 43-51%. We felt that the
option of solvent was critical to this reaction. Accordingly, to further improve the yield of this synthetic
approach, we examined this reaction by using some different organic solvents such as MeOH, THF,
CHCl3, DMF, and dioxane. However, these attempts were unfruitful, and no further improvements to the

yield were observed. Further switching the solvent to H2O or solvent-free condition, no product was
detected by use of the method, the starting materials being recovered unchanged. After many attempts, we
were delight to find that the use of EtOH–AcOH24 solvent system afforded a significant amelioration in
our synthesis, and after a simple optimal experiment, the best results were obtained with good yields
ranging from 74% to 85% when the volume ratio of EtOH and AcOH was 10:1.
Scheme 2. Synthesis of N-aryl-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-ones (5a-i)
In this series of reactions, the effect of substitution groups is not very strong; both the electron-donating
(e.g., Me, Et, OMe) and slightly electron-withdrawing groups (e.g., Cl, Br) worked well, showing little
distinction. However, it is noteworthy that as strong electron-withdrawing groups such as NO2 and CN
were present, the reaction scarcely proceeded and the desired product was detected in negligible amount
that did not warrant isolation. A possible reason is that the presence of the strong electron-withdrawing
group might render the aromatic amines highly electron-deficient and retard the reaction process.
Due to the good yield obtained and to retain the simplicity of the procedure, no further changes in the
reaction conditions were tested, and the above mentioned condition was chosen for the following work. In
diversifying our work on new quinoline-based isoindolin-l-one derivatives, we decided to extend its scope
Scheme 3. Synthesis of N-alkyl-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-ones (5j-p)

to some aliphatic amines (4j-m) and aliphatic diamines (4n-p) as outlined in Scheme 3. Gratifyingly,
these amines were equally amenable to the reaction process without any experimental difficulties,
successfully furnishing the corresponding pyrrolo[3,4-b]quinolin-1-ones 5j-p in comparable yields of
65-82%.
All the newly-synthesized quinoline-based isoindolin-l-ones 5a-p have never been reported and their
structures were easily confirmed by their spectroscopic and analytical data, which were in good
agreement with the compounds expected (see Experimental section). On the basis of these experiments, a
mechanistic proposal portraying the probable sequence of events for the formation of the title compounds
is outlined in Scheme 4. The Williamson-type reaction of the two fragments involves in the first step the
formation of intermediate A, which undergoes subsequent intramolecular nucleophilic cyclization with
participation of the N-atom and the ester C=O group to form a five-membered cyclic system B. After this
cyclization, the elimination of an equiv. of EtOH led to the formation of pyrrolo[3,4-b]quinolin-1-one
ring 6. The whole reactions occurred successively in one-pot effectively. It is worthy to mention that an
example that is particularly relevant to the present discussion is described in the literature,25 wherein
7-isopropyl-1-methylazulen-4-amine undergoes intromolecular ring annulation reactions with 3-position
ester group to yield tricyclic δ-lactams with the elimination of methanol without the need for a catalyst.
Scheme 4. Possible mechanistic pathway for the formation of products 5
In conclusion, we have provided an easy access to the general synthesis of structurally novel and
biologically intriguing quinoline-based isoindolin-l-one derivatives in relatively environmentally benign
EtOH–AcOH (v/v, 10:1) solvent system. These molecules we have synthesized should allow us, in the
future, to investigate structure-activity relationships over various biotests. Moreover, all these molecules
can be used for the synthesis of more complex quinoline-based compounds since chloro group on the
quinoline ring can be further elaborated to a variety of other functional groups, for example, via

metal-catalyzed coupling reactions. Currently, the studies concerning their application in the synthesis of
quinoline heterocycles are underway.
EXPERIMENTAL
The chemicals used in this work were obtained from Fluka and were used without purification. Melting
points (uncorrected) were determined by using WRS-1B melting points apparatus. The IR spectra were
obtained as KBr pellets in the range of 400-4000 cm-1 on a Shimadzu FTIR-8400S spectrophotometer
1
(Shimadzu, Japan). H NMR and 13C NMR spectra were recorded on a Brucker AVANCE NMR
spectrometer. The reported chemical shifts (δ values) are given in parts per million downfield from
tetramethylsilane (TMS) as the internal standard. Elemental analyses were performed for C, H, and N
using an Elementar Vario EL-III element analyzer. The progress of reactions was monitored by thin-layer
chromatography (TLC) on silica gel GF254 using EtOAc/petroleum ether (1:4) as eluent.
Procedure for preparation of ethyl 6-chloro-2-(chloromethyl)quinoline-3-carboxylate (3).
N-(4-Chloro-2-formylphenyl)acetamide (2) (3.96 g, 20 mmol) and ethyl 4-chloro-3-oxobutanoate (3.3 g,
20 mmol) were placed in a 50 mL reaction kettle and dissolved in DMF (20 mL). To the solution thus
obtained, TMSCl (8.7 g, 80 mmol) was carefully added dropwise to the resulting mixture. The kettle was
sealed and heated at 100 °C for 10 h. After cooling the kettle was opened and the mixture was poured into
H2O (1 L) and the mixture thus obtained was allowed to stand at rt in ultrasonic bath for 1 h. The
resulting precipitate was filtered and purified by column chromatography on silica gel using
hexane/EtOAc (10:1) as eluent, affording the pure product 3 in 73% yield. Mp 121-122 oC (Lit.23 122-123
1
oC). IR (KBr) ν/cm-1: 3048, 2985, 1718 (C˙O), 1613, 1560, 1479, 1442, 1289, 1243, 1078; H NMR
(400 MHz, CDCl3) δ (ppm): 1.49 (t, J˙7.2 Hz, 3H, OCH2CH3), 4.51 (q, J˙7.2 Hz, 2H, OCH2CH3), 5.27
(s, 2H, Cl-CH2-Ar), 7.78 (d, J˙8.4 Hz, 1H, Quino-H), 7.92 (s, 1H, Quino-H), 8.08 (d, J˙8.4 Hz, 1H,
13
Quino-H), 8.74 (s, 1H, Quino-H); C NMR (CDCl3, 100 MHz) δ (ppm): 19.78, 51.91, 67.71, 129.69,
132.58, 132.86, 136.45, 138.56, 139.38, 145.48, 152.13, 161.51, 170.88; Anal. Calcd for C13H11Cl2NO2:
C, 54.95; H, 3.90; N, 4.93. Found: C, 55.18; H, 4.15; N, 4.78.
General procedure for the synthesis of N-substituted-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-ones
(5a-m). A mixture of ethyl 6-chloro-2-(chloromethyl)quinoline-3-carboxylate (3) (0.284 g, 1.0 mmol) and
the respective amine (4) (1.0 mmol) was refluxed in EtOH–AcOH (5 mL, v/v, 10:1). After the reaction
has been completed as inferred through thin layer chromatographic studies (complete disappearance of
the starting materials), the reaction was cooled to room temperature and the solvent was removed under
reduced pressure. The residue was purified by column chromatography using hexane/EtOAc (90:10) as
eluent, affording the pure products 5a-m.

7-Chloro-2-phenyl-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one (5a). White solid; reaction time 8 h;
o
yield 81%; mp 264-266 C; IR (KBr) ν/cm-1: 1685 (C=O), 1633, 1578, 1510, 1453, 1428, 1234, 1195,
1118, 834; 1H NMR (CF3COOD, 400 MHz) δ (ppm): 5.90 (s, 2H, CH2N-Ph), 7.74-7.88 (m, 5H, Ben-H),
8.57 (d, J=8.4 Hz, 1H, Quino-H), 8.67 (d, J=8.4 Hz, 1H, Quino-H), 8.77 (s, 1H, Quino-H), 9.80 (s, 1H,
Quino-H); 13C NMR (CF3COOD, 100 MHz) δ (ppm): 51.88, 122.02, 123.38, 127.45, 129.26, 129.74,
129.83, 129.97, 135.00, 137.48, 139.12, 139.45, 143.37, 156.90, 164.32. Anal. Calcd. for C17H11ClN2O:
C, 69.28; H, 3.76; N, 9.50. Found: C, 69.46; H, 3.94; N, 9.43.
7-Chloro-2-(m-tolyl)-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one (5b). White solid; reaction time 8 h;
o
yield 78%; mp 225-227 C; IR (KBr) ν/cm-1: 1683 (C=O), 1633, 1580, 1516, 1454, 1372, 1296, 1271,
1
1188, 1154, 956; H NMR (CF3COOD, 400 MHz) δ (ppm): 2.38 (s, 3H, Me), 5.58 (s, 2H, CH2N-Ar),
7.27 (s, 1H, Ben-H), 7.34-7.38 (m, 3H, Ben-H), 8.26 (d, J=8.4 Hz, 1H, Quino-H), 8.37 (d, J=8.4 Hz, 1H,
Quino-H), 8.46 (s, 1H, Quino-H), 9.48 (s, 1H, Quino-H); 13C NMR (CF3COOD, 100 MHz) δ (ppm):
19.20, 51.65, 120.09, 121.60, 123.64, 126.95, 126.99, 129.23, 129.33, 129.71, 134.31, 136.99, 138.61,
138.92, 140.72, 142.83, 156.50, 163.92; Anal. Calcd for C18H13ClN2O: C, 70.02; H, 4.24; N, 9.07. Found:
C, 69.73; H, 4.13; N, 9.01.
7-Chloro-2-(p-tolyl)-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one (5c). White solid; reaction time 8 h;
o
yield 82%; mp 227-228 C; IR (KBr) ν/cm-1: 1681 (C=O), 1636, 1577, 1503, 1453, 1418, 1354, 1281,
1
1236, 1129, 928; H NMR (CF3COOD, 400 MHz) δ (ppm): 2.34 (s, 3H, Me), 5.53 (s, 2H, CH2N-Ar),
7.29 (d, J=7.8 Hz, 2H, Ben-H), 7.40 (d, J=7.8 Hz, 2H, Ben-H), 8.22 (d, J=8.4 Hz, 1H, Quino-H), 8.33 (d,
J=8.4 Hz, 1H, Quino-H), 8.42 (s, 1H, Quino-H), 9.44 (s, 1H, Quino-H); 13C NMR (CF3COOD, 150 MHz)
δ (ppm): 18.96, 51.68, 121.56, 123.03, 126.94, 19.21, 129.30, 130.04, 131.72, 136.91, 138.57, 138.88,
140.20, 142.72, 156.53, 163.93; Anal. Calcd. for C18H13ClN2O: C, 70.02; H, 4.24; N, 9.07. Found: C,
70.23; H, 4.38; N, 8.92.
7-Chloro-2-(4-ethylphenyl)-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one (5d). White solid; reaction
time 8 h; yield 77%; mp 208-209 oC; IR (KBr) ν/cm-1: 1685 (C=O), 1632, 1577, 1514, 1454, 1417, 1373,
1
1295, 1268, 1195, 835; H NMR (CF3COOD, 400 MHz) δ (ppm): 1.21 (t, J=7.6 Hz, 3H, CH3CH2), 2.67
(q, J=7.6 Hz, 2H, CH3CH2), 5.55 (s, 2H, CH2N-Ar), 7.34 (d, J=8.0 Hz, 2H, Ben-H), 7.44 (d, J=8.4 Hz,
2H, Ben-H), 8.24 (d, J=8.4 Hz, 1H, Quino-H), 8.34 (d, J=8.4 Hz, 1H, Quino-H), 8.43 (s, 1H, Quino-H),
9.45 (s, 1H, Quino-H); 13C NMR (CDCl3, 100 MHz) δ (ppm): 13.37, 27.69, 65.49, 121.60, 123.15,
127.02, 128.95, 129.25, 129.34, 131.88, 136.94, 138.59, 138.90, 142.76, 146.57, 156.57, 163.97; Anal.
Calcd for C19H15ClN2O: C, 70.70; H, 4.68; N, 8.68. Found: C, 70.99; H, 4.48; N, 8.57.
2-(4-(tert-Butyl)phenyl)-7-chloro-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one (5e). White solid;
o
reaction time 8 h; yield 76%; mp 197-198 C; IR (KBr) ν/cm-1: 1683 (C=O), 1632, 1578, 1505, 1480,
1425, 1396, 1275, 1239, 1110, 934; 1H NMR (CF3COOD, 400 MHz) δ (ppm): 1.33 (s, 9H, t-Bu), 5.58 (s,

2H, CH2N-Ar), 7.48 (d, J=7.6 Hz, 2H, Ben-H), 7.59 (d, J=8.0 Hz, 2H, Ben-H), 8.26 (d, J=8.4 Hz, 1H,
Quino-H), 8.37 (d, J=8.4 Hz, 1H, Quino-H), 8.46 (s, 1H, Quino-H), 9.48 (s, 1H, Quino-H); 13C NMR
(CF3COOD, 100 MHz) δ (ppm): 29.42, 34.03, 51.81, 121.64, 122.81, 126.67, 127.08, 129.29, 129.39,
131.61, 136.99, 138.67, 138.96, 142.79, 153.59, 156.69, 164.04; Anal. Calcd for C21H19ClN2O: C, 71.89;
H, 5.46; N, 7.98. Found: C, 72.12; H, 5.71; N, 7.83.
7-Chloro-2-(4-methoxyphenyl)-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one (5f). Yellow solid;
o
reaction time 8 h; yield 83%; mp 248-250 C; IR (KBr) ν/cm-1: 1686 (C=O), 1630, 1579, 1490, 1455,
1414, 1372, 1291, 1221, 999, 832; 1H NMR (CF3COOD, 400 MHz) δ (ppm): 3.99 (s, 3H, OMe), 5.57 (s,
2H, CH2N-Ar), 7.16 (d, J=7.6 Hz, 2H, Ben-H), 7.58 (d, J=7.6 Hz, 2H, Ben-H), 8.27 (d, J=8.4 Hz, 1H,
Quino-H), 8.37 (d, J=8.4 Hz, 1H, Quino-H), 8.47 (s, 1H, Quino-H), 9.48 (s, 1H, Quino-H); 13C NMR
(CF3COOD, 100 MHz) δ (ppm): 55.04, 55.16, 121.63, 125.06, 126.91, 129.29, 129.80, 130.36, 131.74,
137.01, 138.69, 138.99, 140.61, 142.81, 156.49, 164.00; Anal. Calcd for C18H13ClN2O2: C, 66.57; H, 4.03;
N, 8.63. Found: C, 66.26; H, 4.09; N, 8.33.
7-Chloro-2-(4-fluorophenyl)-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one (5g). White solid; reaction
time 8 h; yield 74%; mp 261-263 oC; IR (KBr) ν/cm-1: 1685 (C=O), 1621, 1581, 1508, 1481, 1402, 1380,
1
1336, 1286, 1240, 1116, 945, 874; H NMR (CF3COOD, 400 MHz) δ (ppm): 5.59 (s, 2H, CH2N-Ar),
7.20 (d, J=7.6 Hz, 2H, Ben-H), 7.62 (d, J=7.6 Hz, 2H, Ben-H), 8.28 (d, J=8.4 Hz, 1H, Quino-H), 8.38 (d,
J=8.4 Hz, 1H, Quino-H), 8.47 (s, 1H, Quino-H), 9.51 (s, 1H, Quino-H); 13C NMR (CF3COOD, 100 MHz)
δ (ppm): 51.53, 118.28, 121.62, 125.21, 126.76, 129.25, 129.35, 130.60, 130.62, 137.06, 138.67, 138.99,
143.02, 156.36, 163.84; Anal. Calcd for C17H10ClFN2O: C, 65.29; H, 3.22; N, 8.96. Found: C, 65.46; H,
3.08; N, 9.19.
7-Chloro-2-(4-chlorophenyl)-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one (5h). Yellow solid;
o
reaction time 8 h; yield 78%; mp 265-267 C; IR (KBr) ν/cm-1: 1680 (C=O), 1618, 1515, 1450, 1407,
1
1384, 1338, 1235, 1159, 1074, 864; H NMR (CF3COOD, 400 MHz) δ (ppm): 5.58 (s, 2H, CH2N-Ar),
7.46 (d, J=8.4 Hz, 2H, Ben-H), 7.59 (d, J=8.4 Hz, 2H, Ben-H), 8.25 (d, J=8.4 Hz, 1H, Quino-H), 8.37 (d,
J=8.4 Hz, 1H, Quino-H), 8.45 (s, 1H, Quino-H), 9.48 (s, 1H, Quino-H); 13C NMR (CF3COOD, 100 MHz)
δ (ppm): 51.09, 121.68, 123.72, 126.85, 129.33, 129.42, 129.67, 133.36, 134.88, 137.13, 138.74, 139.08,
142.95, 156.29, 163.63; Anal. Calcd for C17H10Cl2N2O: C, 62.03; H, 3.06; N, 8.51. Found: C, 61.74; H,
2.84; N, 8.30.
2-(4-Bromophenyl)-7-chloro-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one (5i). White solid; reaction
time 8 h; yield 85%; mp 242-243 oC; IR (KBr) ν/cm-1: 1691 (C=O), 1621, 1511, 1446, 1374, 1340, 1294,
1263, 1204, 1118, 874; 1H NMR (CF3COOD, 400 MHz) δ (ppm): 5.58 (s, 2H, CH2N-Ar), 7.53 (d, J=8.4
Hz, 2H, Ben-H), 7.63 (d, J=7.6 Hz, 2H, Ben-H), 8.26 (d, J=8.4 Hz, 1H, Quino-H), 8.37 (d, J=8.4 Hz, 1H,
Quino-H), 8.44 (s, 1H, Quino-H), 9.49 (s, 1H, Quino-H); 13C NMR (CF3COOD, 100 MHz) δ (ppm):

50.94, 121.66, 122.29, 123.75, 126.83, 129.30, 129.40, 132.72, 133.89, 137.11, 138.72, 139.06, 142.91,
156.24, 163.55; Anal. Calcd for C17H10BrClN2O: C, 54.65; H, 2.70; N, 7.50. Found: C, 54.37; H, 2.81; N,
7.21.
7-Chloro-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one (5j). White solid; reaction time 8 h; yield 68%;
1
mp 169-171 oC; IR (KBr) ν/cm-1: 3259 (NH), 1706 (C=O), 1615, 1578, 1497, 1399, 1290, 1165, 847; H
NMR (CF3COOD, 400 MHz) δ (ppm): 5.07 (s, 2H, CH2N-H), 8.11 (d, J=7.6 Hz, 1H, Quino-H), 8.23 (d,
13
J=8.4 Hz, 1H, Quino-H), 8.28 (s, 1H, Quino-H), 9.31 (s, 1H, Quino-H), 11.58 (br s, 1H, NH); C NMR
(CF3COOD, 100 MHz) δ (ppm): 45.65, 121.46, 126.01, 129.07, 129.25, 137.12, 138.61, 139.13, 143.32,
158.36, 167.54; Anal. Calcd for C11H7ClN2O: C, 60.43; H, 3.23; N, 12.81. Found: C, 60.08; H, 3.48; N,
12.49.
7-Chloro-2-methyl-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one (5k). White solid; reaction time 8 h;
o
1
yield 76%; mp 181-182 C; IR (KBr) ν/cm-1: 1692 (C=O), 1617, 1514, 1449, 1374, 1267, 1125, 831; H
NMR (CF3COOD, 400 MHz) δ (ppm): 3.33 (s, 3H, N-Me), 4.61 (s, 2H, CH2N-Ar), 7.79 (d, J=8.4 Hz, 1H,
13
Quino-H), 7.99 (s, 1H, Quino-H), 8.11 (d, J=8.4 Hz, 1H, Quino-H), 8.53 (s, 1H, Quino-H); C NMR
(CF3COOD, 100 MHz) δ (ppm): 29.71, 53.58, 124.98, 128.01, 128.06, 130.47, 131.37, 132.23, 132.83,
147.86, 160.41, 166.02; Anal. Calcd for C12H9ClN2O: C, 61.95; H, 3.90; N, 12.04. Found: C, 62.16; H,
3.97; N, 11.98.
7-Chloro-2-ethyl-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one (5l). White solid; reaction time 8 h;
o
yield 82%; mp 177-179 C; IR (KBr) ν/cm-1: 1689 (C=O), 1619, 1511, 1437, 1373, 1340, 1205, 1182,
1123, 1047, 880; 1H NMR (CF3COOD, 400 MHz) δ (ppm): 1.35 (t, J = 7.2 Hz, 3H, CH2CH3), 3.84 (q, J
= 7.2 Hz, 2H, CH2CH3), 5.14 (s, 2H, CH2N-Ar), 8.19 (d, J=8.4 Hz, 1H, Quino-H), 8.28 (d, J=8.4 Hz, 1H,
Quino-H), 8.39 (s, 1H, Quino-H), 9.36 (s, 1H, Quino-H); 13C NMR (CF3COOD, 100 MHz) δ (ppm):
10.81, 38.39, 48.41, 121.47, 126.94, 126.97, 129.17, 136.66, 138.47, 138.66, 142.29, 156.79, 164.30;
Anal. Calcd for C13H11ClN2O: C, 63.29; H, 4.49; N, 11.36. Found: C, 63.51; H, 4.61; N, 11.28.
2-Benzyl-7-chloro-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one (5m). White solid; reaction time 8 h;
o
yield 74%; mp 198-200 C; IR (KBr) ν/cm-1: 1702 (C=O), 1618, 1584, 1492, 1433, 1367, 1339, 1291,
1
1264, 1203, 1167, 1075, 839; H NMR (CF3COOD, 400 MHz) δ (ppm): 4.98 (s, 2H, NCH2Ph), 5.02 (s,
2H, CH2N-Bn), 7.30-7.36 (m, 5H, Ben-H), 8.22 (d, J=8.4 Hz, 1H, Quino-H), 8.30 (d, J=8.4 Hz, 1H,
Quino-H), 8.43 (s, 1H, Quino-H), 9.45 (s, 1H, Quino-H); 13C NMR (CF3COOD, 100 MHz) δ (ppm):
47.19, 48.54, 121.47, 126.78, 127.69, 128.65, 128.85, 129.18, 132.41, 132.70, 136.71, 138.48, 138.69,
142.53, 156.93, 164.26; Anal. Calcd for C18H13ClN2O: C, 70.02; H, 4.24; N, 9.07. Found: C, 69.82; H,
4.18; N, 9.20.
General procedure for the synthesis of bis(7-chloro-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one)
(5n-p). A mixture of ethyl 6-chloro-2-(chloromethyl)quinoline-3-carboxylate (3) (0.568 g, 2.0 mmol) and

the corresponding diamines (4n-p) (1.0 mmol) was refluxed in EtOH–AcOH (8 mL, v/v, 10:1). After the
reaction has been completed as inferred through thin layer chromatographic studies (complete
disappearance of the starting materials), the reaction was cooled to room temperature and the solvent was
removed under reduced pressure. The residue was purified by column chromatography using
hexane/EtOAc (90:10) as eluent, affording the pure products 5n-p.
2,2’-(Ethane-1,2-diyl)bis(7-chloro-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one) (5n). White solid;
reaction time 10 h; yield 67%; mp >300 oC; IR (KBr) ν/cm-1: 1682 (C=O), 1613, 1510, 1436, 1378, 1343,
1
1264, 1220, 1176, 1124, 862; H NMR (CF3COOD, 400 MHz) δ (ppm): 3.76 (d, J=7.2 Hz, 4H, 2×CH2),
5.35 (s, 4H, 2×CH2N), 8.26 (d, J=8.4 Hz, 2H, Quino-H), 8.42 (d, J=8.4 Hz, 2H, Quino-H), 8.66 (s, 2H,
Quino-H), 9.42 (s, 2H, Quino-H); 13C NMR (CF3COOD, 100 MHz) δ (ppm): 40.32, 41.96, 121.98,
126.33, 127.06, 130.11, 133.54, 138.03, 142.67, 143.32, 157.33, 167.36; Anal. Calcd for C24H16Cl2N4O2:
C, 62.22; H, 3.48; N, 12.09. Found: C, 61.88; H, 3.18; N, 11.72.
2,2’-(Propane-1,3-diyl)bis(7-chloro-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one) (5o). White solid;
reaction time 10 h; yield 64%; mp >300 oC; IR (KBr) ν/cm-1: 1681 (C=O), 1619, 1515, 1450, 1407, 1384,
1338, 1234, 1159, 1074, 864; 1H NMR (CF3COOD, 400 MHz) δ (ppm): 3.35-3.38 (m, 2H, CH2), 3.96 (t,
J=7.2 Hz, 4H, 2×CH2), 5.28 (s, 4H, 2×CH2N), 8.22 (d, J=8.4 Hz, 2H, Quino-H), 8.29 (d, J=8.4 Hz, 2H,
Quino-H), 8.40 (s, 2H, Quino-H), 9.36 (s, 2H, Quino-H); 13C NMR (CF3COOD, 100 MHz) δ (ppm):
25.10, 40.31, 54.05, 121.50, 126.55, 129.23, 129.27, 136.80, 138.61, 138.87, 142.50, 156.96, 164.96;
Anal. Calcd for C25H18Cl2N4O2: C, 62.90; H, 3.80; N, 11.74. Found: C, 62.68; H, 3.73; N, 12.06.
2,2’-(Butane-1,4-diyl)bis(7-chloro-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one) (5p). White solid;
reaction time 10 h; yield 69%; mp >300 oC; IR (KBr) ν/cm-1: 1675 (C=O), 1621, 1581, 1511, 1463, 1407,
1
1380, 1321, 1185, 1061, 874; H NMR (CF3COOD, 400 MHz) δ (ppm): 1.96-1.99 (m, 4H, 2×CH2), 3.94
(t, J=7.2 Hz, 4H, 2×CH2), 5.24 (s, 4H, 2×CH2N), 8.25 (d, J=8.4 Hz, 2H, Quino-H), 8.33 (d, J=8.4 Hz, 2H,
Quino-H), 8.42 (s, 2H, Quino-H), 9.37 (s, 2H, Quino-H); 13C NMR (CF3COOD, 100 MHz) δ (ppm):
24.37, 42.84, 49.14, 121.51, 126.70, 129.23, 136.78, 138.61, 138.83, 142.37, 156.88, 156.91, 164.83;
Anal. Calcd for C26H20Cl2N4O2: C, 63.55; H, 4.10; N, 11.40. Found: C, 63.84; H, 3.90; N, 11.29.
ACKNOWLEDGEMENTS
The authors would like to thank the Scientific Research Foundation of the National Natural Science
Foundation of China (Grant No. 21402011) for financial support.
REFERENCES
1. A. Stierle, J. Hershenhorn, and G. Strobel, Phytochemistry, 1993, 32, 1145.
2. M. Ono, Y. Nishida, C. Masuoko, J.-C. Li, M. Okawa, T. Ikeda, and T. Nohara, J. Nat. Prod., 2004,

67, 2073.
3. V. Ventafridda, G. Martino, V. Mandelli, and A. Emanueli, Clin. Pharmacol. Ther., 1975, 17, 284.
4. J. B. Bartlett, K. Dredge, and A. G. Dalgleish, Nat. Rev. Cancer, 2004, 4, 314.
5. C. S. Cho and W. X. Ren, Tetrahedron Lett., 2009, 50, 2097.
6. D. M. Shacklady-McAtee, S. Dasgupta, and M. P. Watson, Org. Lett., 2011, 13, 3490.
7. E. Mertz, S. Mattei, and S. C. Zimmerman, Bioorg. Med. Chem., 2004, 12, 1517.
8. M. Guo, C.-J. Zheng, M.-X. Song, Y. Wu, L.-P. Sun, Y.-J. Li, Y. Liu, and H.-R. Piao, Bioorg. Med.
Chem. Lett., 2013, 23, 4358.
9. C. B. Sangani, J. A. Makawana, X. Zhang, S. B. Teraiya, L. Lin, and H.-L. Zhu, Eur. J. Med. Chem.,
2014, 76, 549.
10. M. I. Abdullah, A. Mahmood, M. Madni, S. Masood, and M. Kashif, Bioorg. Chem., 2014, 54, 31.
11. R. E. Dolle and K. H. Nelson Jr, J. Comb. Chem., 1999, 1, 235.
12. M. Anzini, S. Vomero, A. Garofalo, A. Cappelli, and A. Cagnotto, Il Farmaco, 1989, 44, 555.
13. K. Isomae, S. Morimoto, H. Hasegawa, K. Morita, and J. Kamei, Eur. J. Pharmacol., 2003, 465, 97.
14. D. S. Bose, M. Idrees, N. M. Jakka, and J. V. Rao, J. Comb. Chem., 2010, 12, 100.
15. A. S. S. H. Elgazwy, Appl. Organometal. Chem., 2009, 23, 32.
16. A. Cappelli, G. Giuliani, S. Valenti, M. Anzini, S. Vomero, G. Giorgi, C. Sogliano, E. Maciocco, G.
Biggio, and A. Concas, Bioorg. Med. Chem., 2008, 16, 3428.
17. Y. Li, C. Zhang, M. Sun, and W. Gao, J. Heterocycl. Chem., 2009, 46, 1190.
18. Y. Li, G. H. Lin, and W. T. Gao, Poly. Arom. Compd., 2012, 32, 469.
19. W. Gao, C. Zhang, and Y. Li, J. Braz. Chem. Soc., 2010, 21, 806.
20. W. Gao, X. Xing, Y. Li, and S. Lan, Tetrahedron, 2014, 70, 2180.
21. Y. Li and W. T. Gao, Heterocycl. Commun., 2013, 19, 405.
22. S. V. Ryabukhin, D. M. Volochnyuk, A. S. Plaskon, V. S. Naumchik, and A. A. Tolmachev,
Synthesis, 2007, 1214.
23. A. B. Atar, S. D. Dindulkar, and Y. T. Jeong, Monatsh. Chem., 2013, 144, 695.
24. H. You, F. Chen, M. Lei, and L. Hu, Tetrahedron Lett., 2013, 54, 2972.
25. A. Kiriazis, I. B. Aumüller, and J. Yli-Kauhaluoma, Tetrahedron Lett., 2011, 52, 1151.